(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

REGIMES DE DOSAGEM DOS ANTICORPOS ANTI-CTLA-4

ArquivadaInvention PatentPCT · US2022078875

Application data

Number

112024008119

Type

Invention Patent

Filing

10/28/2022

Publication

08/13/2024

PCT

US2022078875

Progress at the INPI

  1. Filing10/28/22
  2. Publication08/13/24
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 10/28/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 02/03/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ONCOC4, INC.

US

Inventors

M. D. (pessoa física)

US

P. Z. (pessoa física)

US

Y. L. (pessoa física)

US

Technical data

Priority claims

US

63/273,660 · 10/29/2021

Abstract

REGIMES DE DOSAGEM DOS ANTICORPOS ANTI-CTLA-4. A presente invenção refere-se aos regimes de dosagem dos anticorpos anti-CTLA-4, incluindo o seu uso no tratamento de câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

02/03/2026

RPI 2874

Arquivamento - Art. 33 da LPI

#11.1

11/18/2025

RPI 2863

Notificação de entrada na fase nacional - PCT

#1.3

08/13/2024

RPI 2797

Alteração de dados cadastrais

#1.1

05/07/2024

RPI 2783

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.